These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


118 related items for PubMed ID: 2120745

  • 1. Evaluation of thyrotropin releasing hormone as a therapeutic intervention for endotoxemia.
    Brackett DJ, Schaefer CF, Lerner MR, Holaday JW, Fagraeus L, Wilson MF.
    Regul Pept; 1990 Jul 30; 29(2-3):153-62. PubMed ID: 2120745
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Thyrotropin releasing hormone: effects in monkeys and dogs subjected to experimental circulatory shock.
    Gurll NJ, Holaday JW, Reynolds DG, Ganes E.
    Crit Care Med; 1987 Jun 30; 15(6):574-81. PubMed ID: 3105962
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Respiratory and cardiovascular effects of thyrotropin-releasing hormone as modified by isoflurane, enflurane, pentobarbital and ketamine.
    Schaefer CF, Brackett DJ, Biber B, Lerner MR, Holaday JW, Wilson MF, Fagraeus L.
    Regul Pept; 1989 Mar 30; 24(3):269-82. PubMed ID: 2496439
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Contribution of platelet activating factor to hemodynamic and sympathetic responses to bacterial endotoxin in conscious rats.
    Qi M, Jones SB.
    Circ Shock; 1990 Oct 30; 32(2):153-63. PubMed ID: 2253318
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The effects of H1 and H2 histamine receptor antagonists on the development of endotoxemia in the conscious, unrestrained rat.
    Brackett DJ, Schaefer CF, Wilson MF.
    Circ Shock; 1985 Oct 30; 16(2):141-53. PubMed ID: 2414028
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Endotoxin-induced hypotension in rats is not mediated by prekallikrein activation.
    Kaufmann U, Schapira M, Waeber B, Nussberger J, Brunner HR.
    Circ Shock; 1987 Oct 30; 23(3):215-23. PubMed ID: 2448054
    [Abstract] [Full Text] [Related]

  • 17. Inotropic support during experimental endotoxemic shock: part I. The effects of levosimendan on splanchnic perfusion.
    Cunha-Goncalves D, Perez-de-Sa V, Grins E, Dahm PL, Thörne J, Blomquist S.
    Anesth Analg; 2009 Nov 30; 109(5):1568-75. PubMed ID: 19713249
    [Abstract] [Full Text] [Related]

  • 18. Inotropic support during experimental endotoxemic shock: part II. A comparison of levosimendan with dobutamine.
    Cunha-Goncalves D, Perez-de-Sa V, Larsson A, Thörne J, Blomquist S.
    Anesth Analg; 2009 Nov 30; 109(5):1576-83. PubMed ID: 19713252
    [Abstract] [Full Text] [Related]

  • 19. Thyrotropin releasing hormone in hypovolemia: a hemodynamic evaluation in the rat.
    Sirén AL, Powell E, Feuerstein G.
    Am J Physiol; 1986 Jun 30; 250(6 Pt 2):H1093-101. PubMed ID: 3087219
    [Abstract] [Full Text] [Related]

  • 20. Hemodynamic and metabolic effects of vasopressin blockade in endotoxin shock.
    Matsuoka T, Wisner DH.
    Surgery; 1997 Feb 30; 121(2):162-73. PubMed ID: 9037228
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.